ABOS Shares Outstanding History
Below is a table of the ABOS shares outstanding history going back to 6/29/2021:

Date ABOS Shares Outstanding

Also see: ABOS Market Cap History
ABOS Historical Shares Outstanding:
+24.74% CAGR
ABOS Historical Shares Outstanding: +24.74% CAGR

Mouse over chart for data details
6/29/2021 ...11/15/2021
Acumen Pharmaceuticals is engaged in the discovery and development of targeted therapies for the treatment of Alzheimer's disease ("AD"). Co.'s lead drug candidate, ACU193 is a humanized monoclonal antibody that selectively targets amyloid-beta oligomers, has demonstrated functional and protective effects in in vitro assays, and has demonstrated in vivo safety and pharmacologic activity in multiple animal species, including transgenic models for ADs. Co. and Merck & Co. discovered and developed ACU193 through an eight-year research collaboration. Co. holds exclusive rights to the program. Co. submitted an Investigation Drug Application for ACU193 to the Food and Drug Administration. We show 3 historical shares outstanding datapoints in our coverage of ABOS's shares outstanding history.

Understanding the changing numbers of ABOS shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ABOS versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ABOS by allowing them to research ABOS shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree ABOS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Acumen Pharmaceuticals (ABOS) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ABSI Shares Outstanding History
ABT Shares Outstanding History
ABVC Shares Outstanding History
ACAD Shares Outstanding History
ACCD Shares Outstanding History
ACER Shares Outstanding History
ACET Shares Outstanding History
ACHC Shares Outstanding History
ACHN Shares Outstanding History
ACHV Shares Outstanding History
More Healthcare companies »


ABOS Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2021, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.